Ovarian cancer and KiSS-1 gene expression: A consideration of the use of Kisspeptin plus Kisspeptin aptamers in diagnostics and therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian cancer and KiSS-1 gene expression: A consideration of the use of Kisspeptin plus Kisspeptin aptamers in diagnostics and therapy
Authors
Keywords
Aptamer, Oligonucleotide, Ovarian cancer, Anti-cancer, Kisspeptin, KISS
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 917, Issue -, Pages 174752
Publisher
Elsevier BV
Online
2022-01-11
DOI
10.1016/j.ejphar.2022.174752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2021) Usha Menon et al. LANCET
- A DNA Aptameric Ligand of Human Transferrin Receptor Generated by Cell-SELEX
- (2021) Nan Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020
- (2021) Luoshan Ruan et al. Frontiers in Genetics
- Kissorphin improves spatial memory and cognitive flexibility impairment induced by ethanol treatment in the Barnes maze task in rats
- (2020) Ewa Gibula-Tarlowska et al. BEHAVIOURAL PHARMACOLOGY
- Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders
- (2020) Ali Abbara et al. JOURNAL OF CLINICAL INVESTIGATION
- A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer
- (2020) Na-Oh Yunn et al. NUCLEIC ACIDS RESEARCH
- Exploring and comparing adverse events between PARP inhibitors
- (2019) Christopher J LaFargue et al. LANCET ONCOLOGY
- The kisspeptin derivative - kissorphin reduces the acquisition, expression and reinstatement of ethanol-induced conditioned place preference in rats
- (2019) E. Gibula-Tarlowska et al. ALCOHOL
- The role of Kisspeptin levels in polycystic ovary syndrome: a systematic review and meta-analysis
- (2019) Nicole Paloma de Assis Rodrigues et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The influence of a new derivate of kisspeptin-10 – Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats
- (2019) E. Gibula-Tarlowska et al. BEHAVIOURAL BRAIN RESEARCH
- BRCA1/2 testing: therapeutic implications for breast cancer management
- (2018) Nadine M. Tung et al. BRITISH JOURNAL OF CANCER
- The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
- (2018) Guanyu Ruan et al. OncoTargets and Therapy
- Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells
- (2018) Vincenza Ciaramella et al. Oncotarget
- Aptamer Therapeutics in Cancer: Current and Future
- (2018) Yoshihiro Morita et al. Cancers
- Current Advances in Aptamers for Cancer Diagnosis and Therapy
- (2018) Shin-ichiro Hori et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Kisspeptin/GPR54 System: What Do We Know About Its Role in Human Reproduction?
- (2018) Camila M. Trevisan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Ovarian Cancer Prevention, Screening, and Early Detection
- (2017) Jeremy Chien et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
- (2017) Robert L Coleman et al. LANCET ONCOLOGY
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Introduction to biosensors
- (2016) N. Bhalla et al. Essays in Biochemistry
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- KISS1 Associates with Better Outcome via Inhibiting Matrix Metalloproteinase-9 in Colorectal Liver Metastasis
- (2015) Chengzhan Zhu et al. ANNALS OF SURGICAL ONCOLOGY
- Current approaches in SELEX: An update to aptamer selection technology
- (2015) Mariia Darmostuk et al. BIOTECHNOLOGY ADVANCES
- Global cancer surgery: delivering safe, affordable, and timely cancer surgery
- (2015) Richard Sullivan et al. LANCET ONCOLOGY
- Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing
- (2015) Ti-Hsuan Ku et al. SENSORS
- Aptamers and SELEX in Chemistry & Biology
- (2014) Michael Famulok et al. CHEMISTRY & BIOLOGY
- Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome
- (2014) S.A. Yilmaz et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage
- (2014) C. N. Jayasena et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic Hypogonadism
- (2013) Hichem Miraoui et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors
- (2013) Khadija Elhabazi et al. NEUROPHARMACOLOGY
- Two Families with Normosmic Congenital Hypogonadotropic Hypogonadism and Biallelic Mutations in KISS1R (KISS1 Receptor): Clinical Evaluation and Molecular Characterization of a Novel Mutation
- (2013) Frédéric Brioude et al. PLoS One
- In vivo SELEX for Identification of Brain-penetrating Aptamers
- (2013) Congsheng Cheng et al. Molecular Therapy-Nucleic Acids
- Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicity in Vitro
- (2012) Nathaniel G. N. Milton et al. ACS Chemical Neuroscience
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging
- (2011) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The KISS1 metastasis suppressor: A good night kiss for disseminated cancer cells
- (2010) Benjamin H. Beck et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab toxicities and their management in ovarian cancer
- (2010) Leslie M. Randall et al. GYNECOLOGIC ONCOLOGY
- An Immunohistochemical Study on the Expressional Dynamics of Kisspeptin Neurons Relevant to GnRH Neurons Using a Newly Developed Anti-kisspeptin Antibody
- (2010) Norio Iijima et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Human kisspeptins activate neuropeptide FF2 receptor
- (2010) Y. Lyubimov et al. NEUROSCIENCE
- Riboswitches: Structures and Mechanisms
- (2010) A. D. Garst et al. Cold Spring Harbor Perspectives in Biology
- Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands
- (2010) Shinya Oishi et al. ACS Medicinal Chemistry Letters
- Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis
- (2008) Yingmiao Liu et al. BIOLOGICAL CHEMISTRY
- Metastasis suppressors genes in cancer
- (2008) Lewis J. Stafford et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- From KISS1 to kisspeptins: An historical perspective and suggested nomenclature
- (2008) Michelle L. Gottsch et al. PEPTIDES
- A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study
- (2007) Olivier Valkenburg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search